nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Irinotecan—colon cancer	0.233	0.297	CbGbCtD
Nitrofurantoin—ABCG2—Fluorouracil—colon cancer	0.224	0.285	CbGbCtD
Nitrofurantoin—ABCG2—Vincristine—colon cancer	0.204	0.26	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—colon cancer	0.123	0.157	CbGbCtD
Nitrofurantoin—Chronic liver disease—Methotrexate—colon cancer	0.013	0.0602	CcSEcCtD
Nitrofurantoin—Muscle atrophy—Vincristine—colon cancer	0.00817	0.0379	CcSEcCtD
Nitrofurantoin—Superinfection—Fluorouracil—colon cancer	0.00791	0.0367	CcSEcCtD
Nitrofurantoin—Fibrosis—Fluorouracil—colon cancer	0.00628	0.0292	CcSEcCtD
Nitrofurantoin—Electrocardiogram change—Fluorouracil—colon cancer	0.00628	0.0292	CcSEcCtD
Nitrofurantoin—Superinfection—Capecitabine—colon cancer	0.00553	0.0257	CcSEcCtD
Nitrofurantoin—Electrolyte imbalance—Irinotecan—colon cancer	0.00449	0.0208	CcSEcCtD
Nitrofurantoin—Fibrosis—Capecitabine—colon cancer	0.00439	0.0204	CcSEcCtD
Nitrofurantoin—Dyspnoea exertional—Capecitabine—colon cancer	0.00416	0.0193	CcSEcCtD
Nitrofurantoin—Lung infiltration—Irinotecan—colon cancer	0.004	0.0186	CcSEcCtD
Nitrofurantoin—Anaemia megaloblastic—Methotrexate—colon cancer	0.00396	0.0184	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Capecitabine—colon cancer	0.00385	0.0179	CcSEcCtD
Nitrofurantoin—Fibrosis—Methotrexate—colon cancer	0.00327	0.0152	CcSEcCtD
Nitrofurantoin—Reaction gastrointestinal—Methotrexate—colon cancer	0.0028	0.013	CcSEcCtD
Nitrofurantoin—Nystagmus—Vincristine—colon cancer	0.0027	0.0125	CcSEcCtD
Nitrofurantoin—Nystagmus—Fluorouracil—colon cancer	0.00251	0.0117	CcSEcCtD
Nitrofurantoin—Numbness—Vincristine—colon cancer	0.00232	0.0108	CcSEcCtD
Nitrofurantoin—Tingling sensation—Fluorouracil—colon cancer	0.00223	0.0104	CcSEcCtD
Nitrofurantoin—Sensory loss—Vincristine—colon cancer	0.00222	0.0103	CcSEcCtD
Nitrofurantoin—Numbness—Fluorouracil—colon cancer	0.00217	0.0101	CcSEcCtD
Nitrofurantoin—Sensory loss—Fluorouracil—colon cancer	0.00207	0.00963	CcSEcCtD
Nitrofurantoin—Lung infiltration—Methotrexate—colon cancer	0.00199	0.00925	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Methotrexate—colon cancer	0.00193	0.00898	CcSEcCtD
Nitrofurantoin—Haemoglobin decreased—Capecitabine—colon cancer	0.00182	0.00847	CcSEcCtD
Nitrofurantoin—Pleural effusion—Capecitabine—colon cancer	0.00164	0.00761	CcSEcCtD
Nitrofurantoin—Tingling sensation—Capecitabine—colon cancer	0.00156	0.00725	CcSEcCtD
Nitrofurantoin—Euphoric mood—Fluorouracil—colon cancer	0.00154	0.00716	CcSEcCtD
Nitrofurantoin—Eruption—Methotrexate—colon cancer	0.00152	0.00705	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Irinotecan—colon cancer	0.00144	0.0067	CcSEcCtD
Nitrofurantoin—Renal impairment—Irinotecan—colon cancer	0.00143	0.00664	CcSEcCtD
Nitrofurantoin—Liver disorder—Methotrexate—colon cancer	0.00137	0.00636	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Methotrexate—colon cancer	0.00132	0.00613	CcSEcCtD
Nitrofurantoin—Cyanosis—Methotrexate—colon cancer	0.00132	0.00613	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00126	0.00584	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00123	0.00569	CcSEcCtD
Nitrofurantoin—Pleural effusion—Methotrexate—colon cancer	0.00122	0.00566	CcSEcCtD
Nitrofurantoin—Eosinophilia—Fluorouracil—colon cancer	0.00112	0.00518	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Vincristine—colon cancer	0.00106	0.0049	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Capecitabine—colon cancer	0.00105	0.00486	CcSEcCtD
Nitrofurantoin—Renal failure—Irinotecan—colon cancer	0.00103	0.00479	CcSEcCtD
Nitrofurantoin—Haemolytic anaemia—Capecitabine—colon cancer	0.00101	0.00469	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000985	0.00457	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Capecitabine—colon cancer	0.000965	0.00448	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Vincristine—colon cancer	0.000962	0.00447	CcSEcCtD
Nitrofurantoin—Renal impairment—Capecitabine—colon cancer	0.000957	0.00444	CcSEcCtD
Nitrofurantoin—Vasculitis—Methotrexate—colon cancer	0.000957	0.00444	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Fluorouracil—colon cancer	0.000937	0.00435	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Fluorouracil—colon cancer	0.000897	0.00417	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Methotrexate—colon cancer	0.000877	0.00407	CcSEcCtD
Nitrofurantoin—Alopecia—Vincristine—colon cancer	0.000854	0.00397	CcSEcCtD
Nitrofurantoin—Chills—Irinotecan—colon cancer	0.000845	0.00392	CcSEcCtD
Nitrofurantoin—Alopecia—Irinotecan—colon cancer	0.000832	0.00386	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00082	0.00381	CcSEcCtD
Nitrofurantoin—Flatulence—Irinotecan—colon cancer	0.000808	0.00375	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000803	0.00373	CcSEcCtD
Nitrofurantoin—Alopecia—Fluorouracil—colon cancer	0.000797	0.0037	CcSEcCtD
Nitrofurantoin—Asthma—Capecitabine—colon cancer	0.000787	0.00366	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Methotrexate—colon cancer	0.00078	0.00362	CcSEcCtD
Nitrofurantoin—Anaemia—Vincristine—colon cancer	0.000778	0.00361	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Irinotecan—colon cancer	0.00076	0.00353	CcSEcCtD
Nitrofurantoin—Anaemia—Irinotecan—colon cancer	0.000758	0.00352	CcSEcCtD
Nitrofurantoin—Vertigo—Vincristine—colon cancer	0.000756	0.00351	CcSEcCtD
Nitrofurantoin—Leukopenia—Vincristine—colon cancer	0.000753	0.0035	CcSEcCtD
Nitrofurantoin—Malaise—Irinotecan—colon cancer	0.000739	0.00343	CcSEcCtD
Nitrofurantoin—Vertigo—Irinotecan—colon cancer	0.000736	0.00342	CcSEcCtD
Nitrofurantoin—Leukopenia—Irinotecan—colon cancer	0.000734	0.00341	CcSEcCtD
Nitrofurantoin—Anaemia—Fluorouracil—colon cancer	0.000726	0.00337	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Methotrexate—colon cancer	0.000719	0.00334	CcSEcCtD
Nitrofurantoin—Myalgia—Vincristine—colon cancer	0.000716	0.00333	CcSEcCtD
Nitrofurantoin—Cough—Irinotecan—colon cancer	0.000715	0.00332	CcSEcCtD
Nitrofurantoin—Leukopenia—Fluorouracil—colon cancer	0.000703	0.00326	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000696	0.00323	CcSEcCtD
Nitrofurantoin—Renal failure—Capecitabine—colon cancer	0.00069	0.0032	CcSEcCtD
Nitrofurantoin—Discomfort—Irinotecan—colon cancer	0.000689	0.0032	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Capecitabine—colon cancer	0.000688	0.0032	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Vincristine—colon cancer	0.000687	0.00319	CcSEcCtD
Nitrofurantoin—Confusional state—Irinotecan—colon cancer	0.000674	0.00313	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Vincristine—colon cancer	0.000672	0.00312	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Irinotecan—colon cancer	0.000669	0.00311	CcSEcCtD
Nitrofurantoin—Chest pain—Fluorouracil—colon cancer	0.000668	0.0031	CcSEcCtD
Nitrofurantoin—Myalgia—Fluorouracil—colon cancer	0.000668	0.0031	CcSEcCtD
Nitrofurantoin—Discomfort—Fluorouracil—colon cancer	0.00066	0.00307	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Capecitabine—colon cancer	0.000655	0.00304	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Irinotecan—colon cancer	0.000655	0.00304	CcSEcCtD
Nitrofurantoin—Anorexia—Vincristine—colon cancer	0.000655	0.00304	CcSEcCtD
Nitrofurantoin—Confusional state—Fluorouracil—colon cancer	0.000646	0.003	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Fluorouracil—colon cancer	0.000641	0.00297	CcSEcCtD
Nitrofurantoin—Anorexia—Irinotecan—colon cancer	0.000638	0.00296	CcSEcCtD
Nitrofurantoin—Hepatitis—Capecitabine—colon cancer	0.00063	0.00293	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000627	0.00291	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Capecitabine—colon cancer	0.000627	0.00291	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000626	0.00291	CcSEcCtD
Nitrofurantoin—Paraesthesia—Vincristine—colon cancer	0.000617	0.00286	CcSEcCtD
Nitrofurantoin—Anorexia—Fluorouracil—colon cancer	0.000611	0.00284	CcSEcCtD
Nitrofurantoin—Paraesthesia—Irinotecan—colon cancer	0.000601	0.00279	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vincristine—colon cancer	0.000597	0.00277	CcSEcCtD
Nitrofurantoin—Dyspnoea—Irinotecan—colon cancer	0.000596	0.00277	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Capecitabine—colon cancer	0.000596	0.00277	CcSEcCtD
Nitrofurantoin—Somnolence—Irinotecan—colon cancer	0.000595	0.00276	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vincristine—colon cancer	0.000593	0.00275	CcSEcCtD
Nitrofurantoin—Dyspepsia—Irinotecan—colon cancer	0.000589	0.00273	CcSEcCtD
Nitrofurantoin—Constipation—Vincristine—colon cancer	0.000587	0.00273	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—colon cancer	0.000586	0.00272	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000584	0.00271	CcSEcCtD
Nitrofurantoin—Decreased appetite—Irinotecan—colon cancer	0.000581	0.0027	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—colon cancer	0.00058	0.00269	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000577	0.00268	CcSEcCtD
Nitrofurantoin—Paraesthesia—Fluorouracil—colon cancer	0.000575	0.00267	CcSEcCtD
Nitrofurantoin—Constipation—Irinotecan—colon cancer	0.000572	0.00266	CcSEcCtD
Nitrofurantoin—Dyspnoea—Fluorouracil—colon cancer	0.000571	0.00265	CcSEcCtD
Nitrofurantoin—Somnolence—Fluorouracil—colon cancer	0.00057	0.00264	CcSEcCtD
Nitrofurantoin—Chills—Capecitabine—colon cancer	0.000565	0.00263	CcSEcCtD
Nitrofurantoin—Dyspepsia—Fluorouracil—colon cancer	0.000564	0.00262	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vincristine—colon cancer	0.000562	0.00261	CcSEcCtD
Nitrofurantoin—Decreased appetite—Fluorouracil—colon cancer	0.000557	0.00259	CcSEcCtD
Nitrofurantoin—Alopecia—Capecitabine—colon cancer	0.000557	0.00259	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000553	0.00257	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Irinotecan—colon cancer	0.000551	0.00256	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Irinotecan—colon cancer	0.000547	0.00254	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vincristine—colon cancer	0.000543	0.00252	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vincristine—colon cancer	0.000543	0.00252	CcSEcCtD
Nitrofurantoin—Flatulence—Capecitabine—colon cancer	0.000541	0.00251	CcSEcCtD
Nitrofurantoin—Abdominal pain—Irinotecan—colon cancer	0.000529	0.00246	CcSEcCtD
Nitrofurantoin—Body temperature increased—Irinotecan—colon cancer	0.000529	0.00246	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Fluorouracil—colon cancer	0.000528	0.00245	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—colon cancer	0.000523	0.00243	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000518	0.00241	CcSEcCtD
Nitrofurantoin—Renal failure—Methotrexate—colon cancer	0.000514	0.00239	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Capecitabine—colon cancer	0.000509	0.00236	CcSEcCtD
Nitrofurantoin—Anaemia—Capecitabine—colon cancer	0.000507	0.00235	CcSEcCtD
Nitrofurantoin—Body temperature increased—Fluorouracil—colon cancer	0.000506	0.00235	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Vincristine—colon cancer	0.000506	0.00235	CcSEcCtD
Nitrofurantoin—Malaise—Capecitabine—colon cancer	0.000495	0.0023	CcSEcCtD
Nitrofurantoin—Vertigo—Capecitabine—colon cancer	0.000493	0.00229	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Irinotecan—colon cancer	0.000493	0.00229	CcSEcCtD
Nitrofurantoin—Asthenia—Vincristine—colon cancer	0.000493	0.00229	CcSEcCtD
Nitrofurantoin—Leukopenia—Capecitabine—colon cancer	0.000491	0.00228	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—colon cancer	0.000488	0.00226	CcSEcCtD
Nitrofurantoin—Asthenia—Irinotecan—colon cancer	0.00048	0.00223	CcSEcCtD
Nitrofurantoin—Cough—Capecitabine—colon cancer	0.000479	0.00222	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Fluorouracil—colon cancer	0.000472	0.00219	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vincristine—colon cancer	0.00047	0.00218	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—colon cancer	0.000469	0.00218	CcSEcCtD
Nitrofurantoin—Myalgia—Capecitabine—colon cancer	0.000467	0.00217	CcSEcCtD
Nitrofurantoin—Chest pain—Capecitabine—colon cancer	0.000467	0.00217	CcSEcCtD
Nitrofurantoin—Discomfort—Capecitabine—colon cancer	0.000461	0.00214	CcSEcCtD
Nitrofurantoin—Diarrhoea—Irinotecan—colon cancer	0.000458	0.00213	CcSEcCtD
Nitrofurantoin—Dizziness—Vincristine—colon cancer	0.000454	0.00211	CcSEcCtD
Nitrofurantoin—Confusional state—Capecitabine—colon cancer	0.000451	0.0021	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—colon cancer	0.000444	0.00206	CcSEcCtD
Nitrofurantoin—Dizziness—Irinotecan—colon cancer	0.000442	0.00205	CcSEcCtD
Nitrofurantoin—Diarrhoea—Fluorouracil—colon cancer	0.000438	0.00204	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Capecitabine—colon cancer	0.000438	0.00204	CcSEcCtD
Nitrofurantoin—Vomiting—Vincristine—colon cancer	0.000437	0.00203	CcSEcCtD
Nitrofurantoin—Rash—Vincristine—colon cancer	0.000433	0.00201	CcSEcCtD
Nitrofurantoin—Headache—Vincristine—colon cancer	0.00043	0.002	CcSEcCtD
Nitrofurantoin—Anorexia—Capecitabine—colon cancer	0.000427	0.00198	CcSEcCtD
Nitrofurantoin—Vomiting—Irinotecan—colon cancer	0.000425	0.00197	CcSEcCtD
Nitrofurantoin—Dizziness—Fluorouracil—colon cancer	0.000424	0.00197	CcSEcCtD
Nitrofurantoin—Rash—Irinotecan—colon cancer	0.000422	0.00196	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—colon cancer	0.000421	0.00195	CcSEcCtD
Nitrofurantoin—Headache—Irinotecan—colon cancer	0.000419	0.00195	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—colon cancer	0.000415	0.00192	CcSEcCtD
Nitrofurantoin—Nausea—Vincristine—colon cancer	0.000408	0.00189	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000408	0.00189	CcSEcCtD
Nitrofurantoin—Vomiting—Fluorouracil—colon cancer	0.000407	0.00189	CcSEcCtD
Nitrofurantoin—Rash—Fluorouracil—colon cancer	0.000404	0.00188	CcSEcCtD
Nitrofurantoin—Paraesthesia—Capecitabine—colon cancer	0.000402	0.00187	CcSEcCtD
Nitrofurantoin—Headache—Fluorouracil—colon cancer	0.000401	0.00186	CcSEcCtD
Nitrofurantoin—Dyspnoea—Capecitabine—colon cancer	0.000399	0.00185	CcSEcCtD
Nitrofurantoin—Nausea—Irinotecan—colon cancer	0.000397	0.00185	CcSEcCtD
Nitrofurantoin—Dyspepsia—Capecitabine—colon cancer	0.000394	0.00183	CcSEcCtD
Nitrofurantoin—Decreased appetite—Capecitabine—colon cancer	0.000389	0.00181	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000386	0.00179	CcSEcCtD
Nitrofurantoin—Constipation—Capecitabine—colon cancer	0.000383	0.00178	CcSEcCtD
Nitrofurantoin—Nausea—Fluorouracil—colon cancer	0.000381	0.00177	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—colon cancer	0.000379	0.00176	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—colon cancer	0.000377	0.00175	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Capecitabine—colon cancer	0.000369	0.00171	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—colon cancer	0.000368	0.00171	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—colon cancer	0.000367	0.0017	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Capecitabine—colon cancer	0.000366	0.0017	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—colon cancer	0.000366	0.0017	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—colon cancer	0.000356	0.00165	CcSEcCtD
Nitrofurantoin—Abdominal pain—Capecitabine—colon cancer	0.000354	0.00164	CcSEcCtD
Nitrofurantoin—Body temperature increased—Capecitabine—colon cancer	0.000354	0.00164	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—colon cancer	0.000348	0.00161	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—colon cancer	0.000348	0.00161	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—colon cancer	0.000343	0.0016	CcSEcCtD
Nitrofurantoin—Confusional state—Methotrexate—colon cancer	0.000336	0.00156	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—colon cancer	0.000333	0.00155	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Capecitabine—colon cancer	0.00033	0.00153	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—colon cancer	0.000326	0.00152	CcSEcCtD
Nitrofurantoin—Asthenia—Capecitabine—colon cancer	0.000321	0.00149	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—colon cancer	0.000318	0.00148	CcSEcCtD
Nitrofurantoin—Diarrhoea—Capecitabine—colon cancer	0.000306	0.00142	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000304	0.00141	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—colon cancer	0.000299	0.00139	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—colon cancer	0.000297	0.00138	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—colon cancer	0.000296	0.00138	CcSEcCtD
Nitrofurantoin—Dizziness—Capecitabine—colon cancer	0.000296	0.00137	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—colon cancer	0.000293	0.00136	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—colon cancer	0.00029	0.00135	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000288	0.00134	CcSEcCtD
Nitrofurantoin—Vomiting—Capecitabine—colon cancer	0.000285	0.00132	CcSEcCtD
Nitrofurantoin—Rash—Capecitabine—colon cancer	0.000282	0.00131	CcSEcCtD
Nitrofurantoin—Headache—Capecitabine—colon cancer	0.00028	0.0013	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—colon cancer	0.000275	0.00128	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—colon cancer	0.000273	0.00127	CcSEcCtD
Nitrofurantoin—Nausea—Capecitabine—colon cancer	0.000266	0.00123	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—colon cancer	0.000263	0.00122	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—colon cancer	0.000263	0.00122	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—colon cancer	0.000246	0.00114	CcSEcCtD
Nitrofurantoin—Asthenia—Methotrexate—colon cancer	0.000239	0.00111	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—colon cancer	0.000228	0.00106	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—colon cancer	0.00022	0.00102	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—colon cancer	0.000212	0.000984	CcSEcCtD
Nitrofurantoin—Rash—Methotrexate—colon cancer	0.00021	0.000976	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—colon cancer	0.000209	0.00097	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—colon cancer	0.000198	0.000919	CcSEcCtD
